Johnson & Johnson Stock: Here’s the Level to Buy, and It’s a Steal

Yesterday after the close, Johnson & Johnson  (JNJ)  announced it would end talc-based baby-powder sales globally next year. 

Given that the health-care giant stopped selling it in the U.S. and Canada in 2020, that news likely isn’t too surprising.

The shares have seen selling pressure over the two sessions; they were down about 3.2% at today’s low. While that’s not exactly a harrowing decline, it is noteworthy that J&J hit its lowest stock price since early March.

While most stocks are enjoying a nice run to the upside, Johnson & Johnson has not.

Source: https://www.thestreet.com/investing/heres-the-level-to-buy-johnson-johnson-jnj-stock-and-its-a-steal?puc=yahoo&cm_ven=YAHOO&yptr=yahoo